Sysmex Stock Today
| SSMXF Stock | USD 20.13 0.00 0.00% |
Performance15 of 100
| Odds Of DistressLess than 9
|
Sysmex is trading at 20.13 as of the 26th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 20.13. Sysmex has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Sysmex are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan. SYSMEX CORP operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. The company has 209.24 M outstanding shares. More on Sysmex
Moving against Sysmex Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sysmex Pink Sheet Highlights
| Chairman | Hisashi Ietsugu |
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Sysmex [SSMXF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 13.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sysmex's market, we take the total number of its shares issued and multiply it by Sysmex's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sysmex classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 209.24 M outstanding shares.
Sysmex has accumulated about 56.23 B in cash with 58.74 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 268.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Sysmex Probability Of Bankruptcy
Ownership AllocationSysmex shows a total of 209.24 Million outstanding shares. Sysmex maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sysmex Ownership Details
Sysmex Risk Profiles
| Mean Deviation | 0.4031 | |||
| Standard Deviation | 1.07 | |||
| Variance | 1.14 | |||
| Risk Adjusted Performance | 0.1047 |
Sysmex Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sysmex without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Sysmex Corporate Management
| Kenji Tachibana | Executive VP of Bus. Strategy Devel., Sr. Executive Officer and Member of the Managing Board | Profile | |
| Tomokazu Yoshida | Executive Officer | Profile | |
| Takashi Ono | Executive Officer | Profile | |
| Kensuke Lizuka | Sr Div | Profile | |
| Hiroshi Kanda | Executive Officer | Profile |
Other Information on Investing in Sysmex Pink Sheet
Sysmex financial ratios help investors to determine whether Sysmex Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sysmex with respect to the benefits of owning Sysmex security.